
Tubulis GmbH
Tubulis is a Munich-based biotech company that develops antibody-drug conjugates for cancer therapies. It was acquired by Gilead Sciences in 2025 after raising $617M in funding.
The growth story

Tubulis GmbH grew from 28 to 95 employees between 2022 and 2026, raising $617M along the way, most recently a Series C in October 2025.
About
Tubulis creates antibody-drug conjugates, a class of targeted cancer therapies that combine antibodies with potent drugs. These therapies aim to deliver drugs directly to cancer cells while minimizing damage to healthy tissue.
The company raised $617M before its acquisition by Gilead Sciences in 2025. It had 95 employees at the time of acquisition, with a median tenure of just one year, suggesting rapid scaling before the exit.
Founders and leadership
Research is Tubulis' largest function, with 13 employees. The company's leadership team likely focused on drug development and clinical trials given its biotech focus.












The Tubulis GmbH org chart
Ingo Lehrke (Co-founder & Chief Business Officer) leads 36 mapped leaders with 15 direct reports. Click +N to expand a team; names link to the person’s public profile.
Senior Vice President, Head of Compliance, Risk Management and Data PrivacyExecutive
Departments, and which ones grew

Headcount by function: Research 27 (+4% YoY), Business Development 11 (-27% YoY), Human Resources 8 (+300% YoY), Healthcare Services 6 (+50% YoY), Legal 6 (+500% YoY), Quality Assurance 5 (0% YoY).
Talent flow
Tubulis recruited heavily from MorphoSys, Roche, and Formycon. After the acquisition, 15 employees moved to Gilead Sciences, the acquiring company.

Most common previous employers of Tubulis GmbH staff: MorphoSys (11), Roche (5), Formycon (5), Merck (4), Amgen (4), Bayer (4). Former Tubulis GmbH employees most often moved to Gilead Sciences (15), Ludwig-Maximilians-Universität München (2), BioTalent (1), Amy Foundation Trust (formerly Amy Biehl Foundation Trust) (1), shiftingbio (1), EQT Life Sciences (1).
Alumni worth knowing








Web traffic

Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of

Most common skills at Tubulis GmbH: Biotechnology (31), Pharmaceutics (25), Life Sciences (24), Microsoft Excel (23), Clinical Trials (22), Project Management (22), Good Clinical Practice (GCP) (20), Clinical Development (20).
Where the team actually sits

Tubulis GmbH people are concentrated in Bavaria, Germany (23), Greater Munich Metropolitan Area (12), Germany (6), United States (5).
Search footprint
Tubulis GmbH attracts about 50 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 17 ranking keywords and lost 8 in the last period.
What employees say
- Compensation
- 4.00 / 5
- Career opportunities
- 4.00 / 5
- Senior management
- 5.00 / 5
- Work-life balance
- 5.00 / 5
Frequently asked
Tubulis GmbH has 95 employees as of September 2026.
Tubulis GmbH has raised $617M in total, most recently a Series C round in October 2025.
Tubulis GmbH was founded in 2012 by Ingo Lehrke.
Ingo Lehrke (Co-founder & Chief Business Officer) sits at the top of Tubulis GmbH's reporting structure, with 15 direct reports.
The most common previous employers of current Tubulis GmbH staff are MorphoSys (11 people), Roche (5 people), Formycon (5 people).
Former Tubulis GmbH employees most often move to Gilead Sciences (15), Ludwig-Maximilians-Universität München (2), BioTalent (1).
Tubulis GmbH attracts about 50 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Tubulis GmbH staff are Biotechnology, Pharmaceutics, Life Sciences, Microsoft Excel, Clinical Trials.
Tubulis GmbH staff are concentrated in Bavaria, Germany (23), Greater Munich Metropolitan Area (12), Germany (6).
Tubulis GmbH has about 27 people in Research, up 4% over the past year, as of September 2026.
Tubulis GmbH has about 11 people in Business Development, down 27% over the past year, as of September 2026.
Computed from 76 current and 51 former Tubulis GmbH profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.

